Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised TravelPerk on the transaction, and Bradley Arant Boult Cummings advised AmTrav. TravelPerk announced its acquisition of the industry-leading United States...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Learn to Win in the transaction. Learn to Win, a leading provider of personalized, predictive, and secure enterprise training software,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Serent Capital on the transaction. HarperDB, a leading distributed systems platform, announced a significant growth investment from Serent Capital, a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Kanastra on the transaction. Kanastra, a São Paulo-based tech-driven back office for private credit funds and securitizations in Brazil, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Anterior on the transaction. Anterior, the AI company built by clinicians to transform healthcare administration, announced the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented InduPro in the transaction. InduPro, Inc., a biotechnology company announced an $85 million Series A financing co-led by The Column...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction. Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Genoa Ventures on patent matters related to the transaction. Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, announced it...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Frequence on the transaction, and Latham & Watkins advised Madhive. Madhive, the leading technology company for local Connected Television advertising...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Amber on the transaction. Amber Therapeutics, a UK-based medical technology company, announced it closed a Series A financing, raising $100...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Marengo Therapeutics on the transaction. Marengo Therapeutics announced the expansion of their ongoing oncology research partnership to include TriSTAR, Marengo’s...
You must be a Standard 1 Year member to access this content.
